AtriCure Inc.  

(Public, NASDAQ:ATRC)   Watch this stock  
Find more results for atricure
22.38
+0.57 (2.61%)
May 27 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 21.70 - 22.43
52 week 13.19 - 22.98
Open 21.81
Vol / Avg. 83,591.00/175,465.00
Mkt cap 633.76M
P/E     -
Div/yield     -
EPS -0.51
Shares 28.37M
Beta 0.41
Inst. own 96%
Jul 22, 2015
Q2 2015 AtriCure Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
May 20, 2015
AtriCure Inc Annual Shareholders Meeting
Apr 29, 2015
Q1 2015 AtriCure Inc Earnings Call - Webcast
Apr 29, 2015
Q1 2015 AtriCure Inc Earnings Release
Apr 14, 2015
AtriCure Inc at Needham Healthcare Conference - Webcast
Mar 24, 2015
AtriCure Inc Analyst & Investor Meeting - Webcast
Mar 10, 2015
AtriCure Inc at Barclays Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin -17.62% -15.09%
Operating margin -17.21% -15.23%
EBITD margin - -10.78%
Return on average assets -13.55% -11.99%
Return on average equity -16.18% -15.80%
Employees 320 -
CDP Score - -

Address

6217 Centre Park Dr
WEST CHESTER, OH 45069-3866
United States - Map
+1-513-7554107 (Phone)
+1-302-6745266 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

AtriCure, Inc. is a medical device company providing atrial fibrillation (Afib) solutions. The Company develops, manufactures and sells devices designed for the surgical ablation of cardiac tissue for the treatment of atrial fibrillation and systems designed for the exclusion of the left atrial appendage. The Company’s products include AtriCure’s Synergy Ablation System and Related Radio Frequency (RF) Ablation Devices, Estech’s Radio Frequency Ablation Devices, Cryoablation System and AtriClip Gillinov-Cosgrove Left Atrial Appendage (LAA) System (AtriClip system). In addition, the Company also sells enabling technologies including Lumitip dissector, the MicroPace ORLab system and Estech valve surgical devices. The Company sells its products through a direct sales force and through a wholly owned subsidiary, AtriCure Europe B.V. The Company’s other wholly owned subsidiaries include AtriCure, LLC and Endoscopic Technologies, LLC.

Officers and directors

Richard M. Johnston Independent Chairman of the Board
Age: 80
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Michael H. Carrel President, Chief Executive Officer, Director
Age: 44
Bio & Compensation  - Reuters
M. Andrew Wade CPA Chief Financial Officer, Senior Vice President
Age: 40
Bio & Compensation  - Reuters
Douglas J. Seith Chief Operating Officer
Age: 49
Bio & Compensation  - Reuters
Andrew L. Lux Ph.D. Senior Vice President - R&D, Operations and QA
Age: 63
Bio & Compensation  - Reuters
Patricia J. Kennedy Vice President, General Manager - International
Age: 54
Bio & Compensation  - Reuters
Mark A. Collar Independent Director
Age: 62
Bio & Compensation  - Reuters
Scott William Drake Independent Director
Age: 47
Bio & Compensation  - Reuters
Michael D. Hooven Independent Director
Age: 59
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Elizabeth D. Krell Ph.D. Independent Director
Age: 65
Bio & Compensation  - Reuters